Should we be attempting to stop treatment in patients with JIA who are in remission?
This editorial refers to the article ‘Disease modifying anti-rheumatic drug treatment cycles and rates of flare in juvenile idiopathic arthritis—a tale of Sisyphean endeavour?’ by Emily Bugeja et al. 2025; https://doi.org/10.1093/rheumatology/keaf321.<br/><br/>[No abstract]
Authors
- Ethan S Sen (ORCID: https://orcid.org/0000-0003-0135-6546)
- Clare Pain (ORCID: https://orcid.org/0000-0003-4965-3259)
- A. V. Ramanan
Institutions
- University of Liverpool (GB)
- Bristol Royal Hospital for Children (GB)
- University of Bristol (GB)
- Alder Hey Children's NHS Foundation Trust (GB)
- Great North Children's Hospital (GB)
- Alder Hey Children's Hospital (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-09-08
- DOI
- https://doi.org/10.1093/rheumatology/keaf477
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00